AAAAAA
Results: 1-25/43
Authors:
Bach, JF
Garchon, HJ
van Endert, P
Citation: Jf. Bach et al., Genetics of human type 1 diabetes mellitus, CURR DIR AU, 4, 2001, pp. 1-30
Authors:
Sharif, S
Arreaza, GA
Zucker, P
Mi, QS
Sharif, S
Arreaza, GA
Zucker, P
Mi, QS
Sondhi, J
Naidenko, OV
Kronenberg, M
Koezuka, Y
Delovitch, TL
Gombert, JM
Leite-De-Moraes, M
Gouarin, C
Zhu, R
Hameg, A
Nakayama, T
Taniguchi, M
Lepault, F
Lehuen, A
Bach, JF
Herbelin, A
Citation: S. Sharif et al., Activation of natural killer T cells by alpha-galactosylceramide treatmentprevents the onset and recurrence of autoimmune Type 1 diabetes, NAT MED, 7(9), 2001, pp. 1057-1062
Authors:
Bach, JF
Citation: Jf. Bach, Immunotherapy of insulin-dependent diabetes mellitus, CURR OP IM, 13(5), 2001, pp. 601-605
Authors:
Mahiou, J
Walter, U
Lepault, F
Godeau, F
Bach, JF
Chatenoud, L
Citation: J. Mahiou et al., In vivo blockade of the Fas-Fas ligand pathway inhibits cyclophosphamide-induced diabetes in NOD mice, J AUTOIMMUN, 16(4), 2001, pp. 431-440
Authors:
Bach, JF
Citation: Jf. Bach, Special issue: Proceedings of the International Symposium: Autoimmunity Induced by Infection or Immunization - Merieux Foundation, Annecy, France, J AUTOIMMUN, 16(3), 2001, pp. 173-173
Authors:
Bach, JF
Citation: Jf. Bach, Protective role of infections and vaccinations on autoimmune diseases, J AUTOIMMUN, 16(3), 2001, pp. 347-353
Authors:
Bach, JF
Chatenoud, L
Citation: Jf. Bach et L. Chatenoud, Tolerance to islet autoantigens in type 1 diabetes, ANN R IMMUN, 19, 2001, pp. 131-161
Authors:
Bach, JF
Citation: Jf. Bach, Non-Th2 regulatory T-cell control of Th1 autoimmunity, SC J IMMUN, 54(1-2), 2001, pp. 21-29
Authors:
Bach, JF
Citation: Jf. Bach, Control of autoreactive T cell activation by immunoregulatory T cells (ART), ADV EXP MED, 490, 2001, pp. 67-77
Authors:
Yamamoto, AM
Chernajovsky, Y
Lepault, F
Podhajeer, O
Feldmann, M
Bach, JF
Chatenoud, L
Citation: Am. Yamamoto et al., The activity of immunoregulatory T cells mediating active tolerance is potentiated in nonobese diabetic mice by an IL-4-based retroviral gene therapy, J IMMUNOL, 166(8), 2001, pp. 4973-4980
Authors:
Yamamoto, AM
Gajdos, P
Eymard, B
Tranchant, C
Warter, JM
Gomez, L
Bourquin, C
Bach, JF
Garchon, HJ
Citation: Am. Yamamoto et al., Anti-titin antibodies in myasthenia gravis - Tight association with thymoma and heterogeneity of nonthymoma patients, ARCH NEUROL, 58(6), 2001, pp. 885-890
Authors:
Bach, JF
Chatenoud, L
Citation: Jf. Bach et L. Chatenoud, Cellular and molecular basis of immunosuppression, PATHOLOGY AND IMMUNOLOGY OF TRANSPLANTATION AND REJECTION, 2001, pp. 116-135
Authors:
Bach, JF
Citation: Jf. Bach, New concepts of the etiopathogenesis and treatment of insulin-dependent diabetes mellitus, CL R ALL IM, 19(3), 2000, pp. 217-225
Authors:
Caillat-Zucman, S
Bach, JF
Citation: S. Caillat-zucman et Jf. Bach, Genetic predisposition to IDDM, CL R ALL IM, 19(3), 2000, pp. 227-246
Authors:
Araujo, LM
Puel, A
Gouarin, C
Hameg, A
Mevel, JC
Koezuka, Y
Bach, JF
Mouton, D
Herbelin, A
Citation: Lm. Araujo et al., NKT lymphocyte ontogeny and function are impaired in low antibody-producerBiozzi mice: gene mapping in the interval-specific congenic strains raisedfor immunomodulatory genes, INT IMMUNOL, 12(11), 2000, pp. 1613-1622
Authors:
Sasaki, M
Ansari, A
Pumford, N
de Water, JV
Leung, PSC
Humphries, KM
Szweda, LI
Nakanuma, Y
Roche, TE
Coppel, RL
Bach, JF
Gershwin, ME
Citation: M. Sasaki et al., Comparative immunoreactivity of anti-trifluoroacetyl (TFA) antibody and anti-lipoic acid antibody in primary biliary cirrhosis: Searching for a mimic, J AUTOIMMUN, 15(1), 2000, pp. 51-60
Authors:
Duclos-Vallee, JC
Johanet, C
Bach, JF
Yamamoto, AM
Citation: Jc. Duclos-vallee et al., Autoantibodies associated with acute rejection after liver transplantationfor type-2 autoimmune hepatitis, J HEPATOL, 33(1), 2000, pp. 163-166
Authors:
Hameg, A
Apostolou, I
Leite-de-Moraes, M
Gombert, JM
Garcia, C
Koezuka, Y
Bach, JF
Herbelin, A
Citation: A. Hameg et al., A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen, J IMMUNOL, 165(9), 2000, pp. 4917-4926
Authors:
Marron, MP
Zeidler, A
Raffel, LJ
Eckenrode, SE
Yang, JJ
Hopkins, DI
Garchon, HJ
Jacob, CO
Serrano-Rios, M
Larrad, MTM
Park, Y
Bach, JF
Rotter, JI
Yang, MCK
She, JX
Citation: Mp. Marron et al., Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33, DIABETES, 49(3), 2000, pp. 492-499
Authors:
Pehuet-Figoni, M
Alvarez, F
Bach, JF
Chatenoud, L
Citation: M. Pehuet-figoni et al., Autoantibodies in recent onset type-1 diabetic patients to a Mr 60K microsomal hepatic protein: new evidence for autoantibodies to the type-2 glucosetransporter, CLIN EXP IM, 122(2), 2000, pp. 164-169
Authors:
Yamamoto, AM
Amoura, Z
Johannet, C
Jeronimo, ALC
Campos, H
Koutouzov, S
Piette, JC
Bach, JF
Citation: Am. Yamamoto et al., Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases - New tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases, ARTH RHEUM, 43(3), 2000, pp. 689-698
Authors:
Amoura, Z
Koutouzov, S
Chabre, H
Cacoub, P
Amoura, I
Musset, L
Bach, JF
Piette, JC
Citation: Z. Amoura et al., Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases - Antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus, ARTH RHEUM, 43(1), 2000, pp. 76-84
Authors:
Michel, M
Piette, JC
Roullet, E
Duron, F
Frances, C
Nahum, L
Pelletier, N
Crassard, I
Nunez, S
Michel, C
Bach, JF
Tournier-Lasserve, E
Citation: M. Michel et al., The R131 low-affinity allele of the Fc gamma RIIA receptor is associated with systemic lupus erythematosus but not with other autoimmune diseases in French Caucasians, AM J MED, 108(7), 2000, pp. 580-583
Authors:
Bach, JF
Citation: Jf. Bach, Restoring self-tolerance in diabetics, DIABETES IN THE NEW MILLENNIUM, 2000, pp. 39-46
Authors:
Bach, JF
Herbelin, A
Citation: Jf. Bach et A. Herbelin, On the present limitations of the Th1/Th2 paradigm, IMMUNOLOGIS, 7(1-2), 1999, pp. 12-13